4 Papers
Hui Zhao is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study.
Hongmei Zeng,Maomao Cao,Changfa Xia,Dongmei Wang,Kun Chen,Zheng Zhu,Ruiying Fu,Shaokai Zhang,Jinyi Zhou,Huadong Wang,Xianyun Qi,Shuguang Dai,Yong Chen,Zhong Sun,Hao Ding,Qingwen Li,Hui Zhao,Xuehong Zhang,Jakub Morze,John S. Ji,Feng Sun,Xueqin Yu,Wan-Chin Chen,Chunfeng Qu +23 more
TL;DR: The feasibility and survival benefits of annual screening for hepatocellular carcinoma in individuals at high risk based on hepatitis B surface antigen seropositivity are shown, and HCC screening was associated with improved survival after adjusting for lead-time bias.
14
A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers.
Yuting Wang,Minjie Wang,He Li,Kun Chen,Hongmei Zeng,Xinyu Bi,Zheng Zhu,Yuchen Jiao,Yong Wang,Jian Zhu,Hui Zhao,Xiang Liu,Chunyun Dai,Chunsun Fan,Can Zhao,Deyin Guo,Hong Zhao,Jianguo Zhou,Dongmei Wang,Zhiyuan Wu,Xinming Zhao,Wei Cui,Xuehong Zhang,Xuehong Zhang,Jianqiang Cai,Wanqing Chen,Chunfeng Qu +26 more
TL;DR: A risk-stratified HCC prediction model for HBsAg-positive male adults shows gender disparity and identified individual’s risk for HCC occurrence within short-term for their HCC precision surveillance.
Serum alanine aminotransferase to hemoglobin ratio and radiological features predict the prognosis of postoperative adjuvant TACE in patients with hepatocellular carcinoma
Zicong Xia,Yulou Zhao,Hui Zhao,Jing Zhang,Cheng-Dong Liu,Wen-Tsoung Lu,Lele Wang,Kang Chen,Junkai Yang,Jiahong Zhu,Wenjing Zhao,Aiguo Shen +11 more
TL;DR: A preliminary study confirmed the prognostic value of AHR, PTC, and IRE and established a nomogram that can predict the overall survival (OS) of patients with hepatocellular carcinoma treated with PA-TACE.
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
Chunfeng Qu,Yuting Wang,Pei Wang,Kun Chen,Minjie Wang,Hongmei Zeng,Jianquan Lu,Qianqian Song,Bill H. Diplas,Tan Da,Chunsun Fan,Qigao Guo,Zheng Zhu,Huihui Yin,Liping Jiang,Xixi Chen,Hui Zhao,Huan He,Yong Wang,Guangyu Li,Xinyu Bi,Xinming Zhao,Taoyang Chen,Hongping Tang,Chuanguo Lv,Dongmei Wang,Wanqing Chen,Jianguo Zhou,Hong Zhao,Jianqiang Cai,Xiaoyue Wang,Wang Sizhen,Hai Yan,Yi Xin Zeng,Webster K. Cavenee,Yuchen Jiao +35 more
TL;DR: A liquid biopsy assay to identify HCC from the surface antigen of hepatitis B virus positive asymptomatic individuals in the community population was developed and showed 100% sensitivity, 94% specificity, and 17% positive predictive value in the validation cohort.